NovaBridge Biosciences (NBP) Goodwill (2018 - 2023)

NovaBridge Biosciences (NBP) has reported Goodwill for 6 consecutive years, with $22.4 million the latest figure, recorded in Q2 2023.

• Quarterly Goodwill fell 7.63% year-over-year to $22.4 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $22.4 million (down 7.63% YoY) and the FY2022 annual result came in at $23.6 billion, up 92295.44% from the prior year.
• Goodwill retreated to $22.4 million in Q2 2023 per NBP's latest filing, from $22.9 million in the prior quarter.
• Over the last five years, Goodwill for NBP reached as high as $25.4 billion in Q4 2021 and fell as low as $22.4 million in Q2 2023.
• A 5-year average of $2.8 billion and a median of $23.9 million in 2020 frame the typical range for Goodwill.
• Annual changes were most pronounced in 2021 — Goodwill soared 103555.76% — and 2022, when it plunged 99.91%.
• Year by year, Goodwill stood at $23.1 million in 2019, then increased by 6.35% to $24.5 million in 2020, then surged by 103555.76% to $25.4 billion in 2021, then tumbled by 99.91% to $22.9 million in 2022, then fell by 1.92% to $22.4 million in 2023.
• According to Business Quant data, Goodwill over the past three periods registered $22.4 million, $22.9 million, and $24.3 million for Q2 2023, Q4 2022, and Q2 2022 respectively.